Filing Details
- Accession Number:
- 0000899243-21-020279
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-05-20 20:30:13
- Reporting Period:
- 2021-05-06
- Accepted Time:
- 2021-05-20 20:30:13
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1501134 | Invitae Corp | NVTA | Services-Medical Laboratories (8071) | 271701898 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1588984 | D Shelly Guyer | C/O Invitae Corporation 1400 16Th Street San Francisco CA 94103 | Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2021-05-06 | 27,000 | $0.00 | 255,309 | No | 4 | A | Direct | |
Common Stock | Disposition | 2021-05-18 | 3,424 | $27.49 | 251,885 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | A | Direct | |
No | 4 | S | Direct |
Footnotes
- Shares issued upon settlement of a restricted stock unit award that vests in four equal installments, with 25% of the shares vesting on May 15, 2021, and 25% of the shares vesting on each of May 15, 2022, 2023 and 2024, subject to continued service with the Issuer through the applicable vesting dates.
- Includes an aggregate of 114,317 shares of common stock issuable pursuant to restricted stock units that have not vested.
- Represents the sale of shares to cover tax withholding obligations associated with the vesting and settlement of restricted stock units.